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Abstract 
p38 MAP kinase (MAPK) is activated in response to environmental stress, cytokines and 
DNA damage, and mediates death, cell differentiation and cell cycle checkpoints. The intra-
cellular localization of p38 MAPK upon activation remains unclear, and may depend on the 
stimulus. We show here that activation of p38 MAPK by stimuli that induce DNA double 
strand breaks (DSBs), but not other stimuli, leads to its nuclear translocation. In addition, 
naturally occurring DSBs generated through V(D)J recombination in immature thymocytes 
also promote nuclear accumulation of p38 MAPK. Nuclear translocation of p38 MAPK does 
not require its catalytic activity, but is induced by a conformational change of p38 MAPK 
triggered by phosphorylation within the active site. The selective nuclear accumulation of 
p38 MAPK in response to DNA damage could be a mechanism to facilitate the phosphory-
lation of p38 MAPK nuclear targets for the induction of a G2/M cell cycle checkpoint and 
DNA repair. 
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Introduction 
The p38 MAPK family are a group of kinases 
belonging to the MAPK family, together with the JNK 
and ERK groups. There are four different isoforms of 
p38 MAPK (p38α, p38β, p38γ, and p38δ). p38α is the 
most abundant and widely expressed, but it is also 
the only isoform with a non-redundant function in 
vivo [1-5]. p38 MAPK is activated following phos-
phorylation at Thr180/Tyr182 within the active site. 
This phosphorylation is mediated primarily by up-
stream MKK3 and MKK6, although in vitro, MKK4 
may also contribute to p38 MAPK activation in the 
absence of MKK3/MKK6 [6-8]. MKK3 and MKK6 in 
turn are regulated by phosphorylation through up-
stream MAPK kinase kinases (MAPKKK).   
The p38 MAPK pathway is activated in response 
to environmental stress (UV, ionizing radiation, oxi-
dative stress, and FAS ligand) and cytokines (e.g. 
TNFα) [9]. Activation of the p38 MAPK pathway by 
cytokines and receptor ligands, normally leads to cell 
differentiation. Activation of p38 MAPK through en-
vironmental stress can mediate cell death. In response 
to DNA damage stimuli that induce DSBs (ionizing 
radiation, UV, chemotherapeutic drugs) activation of 
p38 MAPK can also lead to the induction of a G2/M 
cell cycle checkpoint through p53-dependent and in-
dependent mechanisms [10-15]. p38 MAPK can also 
be activated by naturally generated DSBs in imma-
ture thymocytes at the CD4-CD8-  double negative 
(DN)3 stage, whilst they undergo V(D)J recombina-
tion of the T cell receptor (TCR)β gene.   
Despite the number of studies showing activa-
tion of p38 MAPK in response to DNA damage in-
ducing stimuli and its role in the G2/M checkpoint, 
the mechanism by which p38 MAPK is activated, and 
its intracellular distribution is unclear. Unlike other 
MAPK, p38 MAPK has no nuclear localization signal, 
and has been shown to be distributed throughout the 
cytosol and nucleus [16]. However, in response to Int. J. Biol. Sci. 2009, 5 
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specific stimuli p38 MAPK has been shown to pref-
erentially accumulate in the cytosol [17]. Depending 
on the stimuli, p38 MAPK can have a variety of sub-
strates, including transcription factors (ATF2, MEF2), 
protein kinases (MnK, MAPKAPK2), death/survival 
molecules (Bcl2, caspases), and cell cycle control fac-
tors (cyclin D1) [18-22]. Thus, it is possible that the 
intracellular distribution of p38 MAPK is associated 
with its substrate specificity and determined by the 
nature of the stimuli. 
We show here that p38 MAPK translocates to 
the nucleus specifically upon activation by stimuli 
that induce DSBs, and that p38 MAPK nuclear trans-
location is triggered by a conformational change in-
duced by phosphorylation within the active site. This 
specific nuclear translocation could be relevant for 
this pathway to regulate the initiation of a G2/M cell 
cycle checkpoint and promote DNA repair. 
Results 
DNA Damage Induces the Nuclear Transloca-
tion of p38 MAPK. 
Despite its role in the induction of cell cycle 
checkpoints in response to DSBs inducing stimuli, 
little is known about the intracellular distribution of 
p38 MAPK following its activation by DSBs. Unlike 
other MAPKs, p38 MAPK lacks a specific nuclear lo-
calization sequence. We therefore investigated the 
intracellular localization of p38 MAPK in response to 
UV radiation, which induces DNA single strand 
damage that can lead to the formation of DNA DSBs 
[23]. 293T cells were transfected with p38 MAPK and 
exposed to UV irradiation. Cells were stained for p38 
MAPK and examined by confocal microscopy. In un-
exposed cells, p38 MAPK was distributed throughout 
the cell, but predominantly outside the nucleus (Fig 
1A). Interestingly, following exposure to UV, p38 
MAPK accumulated in the nucleus (Fig 1A). The 
generation of DSBs in response to UV exposure was 
monitored by staining cells for the presence of phos-
phorylated H2AX at Ser139 (termed γH2AX), a 
known indicator of DNA DSBs (Fig 1A) [24, 25]. To 
corroborate that this nuclear translocation was due to 
the presence of DSBs, cells were exposed to 
X-radiation, a known source of ionizing radiation that 
induces DNA DSBs. Similar to UV exposure, 
X-radiation also caused a translocation of p38 MAPK 
to the nucleus (Fig 1A). To visualize phospho-p38 in 
this study, an antibody that recognizes p38 MAPK 
which has been dually phosphorylated on both 
Thr180/Tyr182 was used. Staining for phospho-p38 
MAPK showed no phosphorylation of p38 MAPK in 
unexposed cells (Fig 1B), but high levels of phos-
phorylated p38 MAPK specifically in the nuclei of 
cells exposed to either UV or X-radiation (Fig 1B). 
Thus, nuclear localization of p38 MAPK in response 
to DNA damage inducing stimuli is associated with 
its phosphorylation. 
Since a nuclear translocation of p38 MAPK upon 
cell stimulation has not been previously reported, we 
examined the distribution of p38 MAPK in response 
to other known activators which do not induce DNA 
damage. Treatment with TNFα, one of the first iden-
tified activators of p38 MAPK, did not cause p38 
MAPK nuclear accumulation (Fig 1C), although p38 
MAPK phosphorylation was induced (Fig 1D). Simi-
larly, Fas ligation or PMA activated p38 MAPK (Fig 
1D), but did not promote its nuclear accumulation 
(Fig 1C). Thus, p38 MAPK is selectively translocated 
to the nucleus in response to stimuli that generate 
DSBs.  
 
Phosphorylation of p38 MAPK is Essential for its 
Nuclear Translocation in Response to DNA 
Damage. 
p38 MAPK is activated following phosphoryla-
tion at Thr180/Tyr182 by upstream MAPKKs [16]. In 
order to assess whether phosphorylation of p38 
MAPK was required for its nuclear translocation fol-
lowing DNA damage, cells were transfected with ei-
ther wild type p38 MAPK or a dominant negative p38 
MAPK (dnp38) mutant where Thr180/Tyr182 have 
been substituted with non-phosphorylatable Ala/Phe 
residues respectively [16]. Whilst wild type p38 
MAPK was distributed throughout the cells, dnp38 
was totally excluded from the nucleus in untreated 
cells (Fig 2A). In contrast to wild type p38 MAPK 
which accumulated preferentially in the nucleus, 
dnp38 remained in the cytosol and was excluded 
from the nucleus following exposure to X-radiation 
(Fig 2A). The presence of γH2AX  sho wed that c ells 
transfected with dnp38 have DSBs, indicating the ac-
tivation of the DNA damage response (Fig 2A). Simi-
lar to X-radiation, UV exposure failed to induce nu-
clear translocation of dnp38 (Fig 2B). Thus, phos-
phorylation of p38 MAPK at Thr180/Tyr182 is required 
for the nuclear translocation of p38 MAPK following 
DNA damage.   
Phosphorylation of p38 MAPK leads to its acti-
vation by inducing a conformational change. To dis-
sociate whether p38 MAPK activity, or solely the 
conformational change caused by the phosphoryla-
tion was required for nuclear translocation we exam-
ined the effect of a pharmacological p38 MAPK in-
hibitor, SB203580 [26], which binds at the catalytic 
site and blocks its activity. Cells were transfected Int. J. Biol. Sci. 2009, 5 
 
http://www.biolsci.org 
430
with wild type p38 MAPK and pretreated with 
SB203580 prior to X-radiation exposure. Interestingly, 
SB203580 did not prevent nuclear translocation of p38 
MAPK in response to X-radiation (Fig 2C). Similarly, 
no effect of SB203580 on UV-induced nuclear trans-
l o c a t i o n  o f  p 3 8  M A P K  c o u l d  b e  d e t e c t e d  ( F i g  2 D ) .  
Thus, catalytic activity of p38 MAPK is not required 
for its nuclear translocation in response to DNA 
damage, suggesting that a conformational change 
caused by upstream phosphorylation promotes its 
nuclear transport. 
 
 
 
 
 
 
 
Figure 1. Nuclear Translocation of p38 MAPK in Response to DNA Damage Stimuli. (A) 293T cells were 
transiently transfected with wild type p38 MAPK and left unstimulated (unstim), or treated with UV irradiation (UV), or 
X-radiation (X-Ray). Cells were stained for p38 MAPK (green) and γH2AX (red). TOPRO-3 (blue) was used as a nuclear 
marker. (B) 293T cells were transfected and treated as in (A). Cells were stained for p38 MAPK (green), and phospho-p38 
MAPK (red). ‘Merge’ indicates the merged images of TOPRO-3 and p38 MAPK or TOPRO-3, p38 MAPK, and phospho-p38 
MAPK. (C) and (D) 293T transfected cells as in (A) were treated with TNFα (10 ng/ml), Ig-FASL (200 ng/ml) and cross 
linker (4 μg/ml), or PMA (10 ng/ml) for 30 mins. Staining and confocal analysis were performed as described in (A). Data 
representative of at least three independent experiments. Int. J. Biol. Sci. 2009, 5 
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Figure 2. p38 MAPK Phosphorylation is Required for its Nuclear Translocation. (A) 293T cells were transiently 
transfected with either wild type or dnp38 MAPK and left unstimulated (unstim), or treated with X-Ray. Cells were stained 
for p38 MAPK (green) and γH2AX (red). TOPRO-3 (blue) was used as a nuclear marker. (B) 293T cells were transfected 
with dnp38 MAPK and left unstimulated (unstim), or treated with UV irradiation (UV). Staining and confocal analysis were 
performed as described in (A). (C) and (D) 293T cells transiently transfected with wild type p38 MAPK, were treated with 
SB203580 (5 μM) 40 mins, and left unstimulated or exposed to X-Ray (C) or UV (D). Staining and confocal analysis were 
performed as described in (A). ‘Merge’ indicates the merged images of TOPRO-3 and p38 MAPK. Data representative of at 
least three independent experiments. 
 
 
Unlike SB203580, BIRB 796 belongs to a new 
class of p38 MAPK inhibitors, inhibiting p38α MAPK 
via a novel mechanism which indirectly competes 
with ATP binding by inducing a conformational 
change [27]. Binding of BIRB 796 to p38 MAPK causes 
a large structural reorganization of the activation 
loop (residues 171-184) and the resulting structure is 
non-compatible with ATP-binding. This conforma-
tional change can resemble that induced by phos-
phorylation at Thr180/Tyr182. Since SB203580 did not 
affect p38 MAPK translocation, despite inhibiting p38 
MAPK catalytic activity, we investigated whether a 
conformational change induced by BIRB 796 could 
affect the localization of the dnp38 mutant by mim-
icking the effect of phosphorylation. Cells were 
transfected with dnp38 and pretreated with BIRB 796 
prior to UV exposure. Although dnp38 remained in 
the cytosol, the presence of BIRB 796 restored its nu-
clear translocation (Fig 3A). In contrast, dnp38 did 
not translocate to the nucleus in the presence of 
SB203580 (Fig 3A). To show that both compounds 
were able to inhibit the activity of p38 MAPK in these 
cells, we examined downstream targets of p38 
MAPK. We analyzed the activation of Mnk kinase Int. J. Biol. Sci. 2009, 5 
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since it is a primary target for p38 MAPK but not for 
JNK [19]. Mnk1/2 mediate phosphorylation and ac-
tivation of the translation initiator factor 4E (eIF-4E), 
and phosphorylation of eIF-4E is usually used as a 
read out system for activity of Mnk [19]. eIF-4E 
phosphorylation was induced upon UV exposure, but 
the presence of either SB203580 or BIRB 796 blocked 
its phosphorylation (Fig 3B). Thus, both pharmacol-
ogical compounds are able to interfere with the cata-
lytic activity of p38 MAPK. We also examined the 
effect of both inhibitors on the phosphorylation of 
p38 MAPK at the Thr180/Tyr182 motif by upstream 
MAPKK. According to its mechanism of action, 
SB203580 did not interfere with the phosphorylation 
of p38 MAPK (Fig 3C). In contrast, BIRB 796 reduced 
the phosphorylation of p38 MAPK at this domain, 
supporting the conformational change effect that this 
compound has (Fig 3C). Analysis of p38 MAPK cel-
lular localization in non-UV exposed cells treated 
with BIRB 796, indicated that BIRB 796 by itself was 
also able to promote accumulation of dnp38 to the 
nucleus in the absence of other stimuli (Fig 3D). This 
further supports that p38 MAPK activation loop 
phosphorylation is critical to its nuclear translocation 
by inducing a conformational change. 
Nuclear Translocation of Endogenous p38 MAPK 
in Thymocytes Following Ionizing Radiation. 
To show that nuclear accumulation of endoge-
nous p38 MAPK in response to ionizing radiation 
also occurs in primary cells, we examined endoge-
nous p38 MAPK distribution in thymocytes. Total 
t h y m o c y t e s  f r o m  w i l d  t y p e  m i c e  w e r e  e x p o s e d  t o  
X-radiation, and stained for endogenous p38 MAPK. 
The intracellular distribution of p38 MAPK was ex-
amined by confocal microscopy. Unlike 293T cells, 
thymocytes have a very limited amount of cytoplasm 
(immediately surrounding the nucleus). Nonetheless, 
p38 MAPK could be detected in the cytosol of thy-
mocytes prior to exposure (Fig 4A). However, expo-
sure to ionizing radiation resulted in a nuclear accu-
mulation of p38 MAPK (Fig 4A). These results further 
demonstrate that p38 MAPK specifically translocates 
to the nucleus in response to DNA damage.   
 
 
 
Figure 3. p38 MAPK Phosphorylation Induces a Conformational Change that is Required for Nuclear 
Translocation. (A) 293T cells transfected with dnp38 MAPK were treated with BIRB 796 (5 μM) 40 mins, and exposed to 
UV irradiation (UV). Cells were stained for p38 MAPK (green) and TOPRO-3 (blue). ‘Merge’ indicates the merged images of 
TOPRO-3 and p38 MAPK. (B) 293T cells transiently transfected with wild type p38 MAPK, were left unstimulated or 
exposed to UV in the presence or absence of SB203580 (5 μM) or BIRB 796 (5 μM). Whole cell extracts were then ex-
amined for phosphorylated eIF-4E by Western blot analysis. Actin levels were examined as a loading control. (C) Cells were 
exposed and treated as described in (B) and whole cell extracts were used to examine phospho-p38 MAPK and total p38 
MAPK by Western blot analysis. (D) 293T cells transfected with dnp38 MAPK were treated with vehicle or BIRB 796 for 40 
mins. Cells were stained as described in (A). Data representative of at least three independent experiments. Int. J. Biol. Sci. 2009, 5 
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Figure 4. Nuclear Translocation of Endogenous p38 MAPK in Thymocytes in Response to DNA Damage. 
(A) Total thymocytes from wild type mice were left unstimulted (unstim), or exposed to X-Ray, and stained for p38 MAPK 
(red) and YoYo (green). (B) Whole cell extracts from total and purified DN thymocytes from wild type and 
MKK3
-/-/MKK6
+/- mice were examined for phospho-p38 MAPK and p38 MAPK by western blot analysis (C) Total thy-
mocytes from both wild type and MKK3
-/-/MKK6
+/- mice were left unstimulted (unstim), or treated with X-Ray, and stained 
for p38 MAPK (red), γH2AX (green), and TOPRO-3 (blue). ‘Merge’ indicates the merged images of TOPRO-3 and p38 
MAPK. A higher magnification view of the insets (marked with white boxes) in the ‘merge’ panels is shown on the right side. 
(D) Graph displaying the percentage of cells demonstrating p38 MAPK nuclear accumulation. Determined in total thy-
mocytes from WT and MKK3
-/-/MKK6
+/- mice left unsitmulated or exposed to X-Ray (total count >150 cells per population, 
counted from 3 independent areas of visualization). Error bars represent SEM. Data representative of at least three in-
dependent experiments. 
 
MKK3 and MKK6 are the main MAPKKs that 
phosphorylate and activate p38 MAPK [28]. Double 
deficiency for both MKK3 and MKK6 
(MKK3-/-/MKK6-/-) in mice causes embryonic lethal-
ity, similar to p38α MAPK deficiency [8]. In contrast, 
MKK3-/-/MKK6+/- mice are viable, but p38 MAPK 
activation is severely compromised (Sabio, G. et al 
unpublished data). To confirm that activation of p38 
MAPK was impaired in thymocytes from these mice 
we examined the levels of phospho-p38 MAPK by 
Western blot analysis. The levels of phospho-p38 
MAPK were reduced in total thymocytes from 
MKK3-/-/MKK6+/- mice compared with the levels in 
wild type thymocytes (Fig 4B). We also examined the 
levels of activated p38 MAPK in the double negative 
(DN) thymocyte population where p38 MAPK is con-
stitutively activated [29]. The levels of phospho-p38 
M A P K  w e r e  a l s o  s u b s t a n t i a l l y  r e d u c e d  i n  D N  t h y -
mocytes from MKK3-/-/MKK6+/- mice (Fig 4B). Thus, 
activation of p38 MAPK is impaired in 
MKK3-/-/MKK6+/- thymocytes. Wild type and 
MKK3-/-/MKK6+/- thymocytes were then exposed to 
X-radiation, and p38 MAPK intracellular distribution 
was assessed. As described above, X-radiation in-
duced the nuclear accumulation of p38 MAPK in wild 
type total thymocytes (Fig 4C and 4D). In contrast, 
nuclear translocation of p38 MAPK was severely 
compromised in MKK3-/-/MKK6+/- thymocytes (Fig 
4C). The presence of DSBs, as determined by γH2AX 
staining, was comparable between exposed wild type 
and MKK3-/-/MKK6+/- thymocytes (Fig 4C), indicat-
ing that MKK3-/-/MKK6+/- thymocytes responded to 
X-radiation. These results demonstrate that in pri-
mary cells, endogenous p38 MAPK translocates to the 
nucleus in response to DNA damage, and that nu-
clear translocation requires its phosphorylation.   
V(D)J recombination mediated DSBs Induce the 
Nuclear Translocation of p38 MAPK. 
p38 MAPK is activated by V(D)J-mediated DSBs Int. J. Biol. Sci. 2009, 5 
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during recombination of the TCRβ g e n e  i n  D N 3  
(CD25+ CD44-) thymocytes and it is inactivated once 
DN3 thymocytes differentiate into DN4 (CD25- 
CD44-) thymocytes, and DNA repair has taken place 
[30]. We therefore examined whether activation of 
p38 MAPK in response to V(D)J-mediated DSBs in 
DN3 thymocytes also leads to nuclear accumulation 
of this kinase. DN3 and DN4 thymocytes were iso-
lated from wild type mice by cell sorting, stained for 
p38 MAPK and examined by confocal microscopy. 
p38 MAPK localized primarily in the nucleus of most 
DN3 thymocytes, whilst it was excluded from the 
nucleus in DN4 thymocytes (Fig 5A). Thus, nuclear 
accumulation of p38 MAPK in DN3 thymocytes cor-
relates with the activation of p38 MAPK by 
V(D)J-mediated DSBs in this thymocyte population. 
To demonstrate that the nuclear accumulation of p38 
MAPK in DN3 thymocytes was caused by 
V(D)J-mediated DSBs, we examined the localization 
of p38 MAPK in DN3 thymocytes isolated from 
RAG1 deficient mice since they have no 
V(D)J-mediated DSBs, due to the lack of the RAG1 
recombinase. Minimal nuclear accumulation of p38 
MAPK was detected in DN3 thymocytes from RAG1 
deficient mice compared with that in wild type DN3 
thymocytes (Fig 5B and 5C). Unlike RAG1-deficient 
thymocytes, thymocytes from SCID (Severe Com-
bined Immuno Deficient) mice undergo V(D)J recom-
bination, but they are unable to repair DNA damage 
due to a deficiency in DNA-PK. As a result, thymo-
cyte development in these mice is also arrested at the 
DN3 stage, but V(D)J-mediated DNA DSBs are con-
tinuously present in these cells since they cannot be 
repaired. In contrast to DN3 thymocytes from RAG1 
mice, most SCID DN3 thymocytes showed p38 
MAPK in the nucleus (Fig 5C). Together, these results 
show that V(D)J-mediated DSBs promote the nuclear 
accumulation of endogenous p38 MAPK, comparable 
to the response observed upon ionizing irradiation 
exposure.  
 
 
Figure 5. V(D)J-mediated DSBs Induce p38 MAPK Translocation in DN3 Thymocytes. (A) DN3 and DN4 
thymocytes purified from wild type mice, were stained with for p38 MAPK (red) and YoYo (green). (B) DN3 and DN4 
thymocytes purified from wild type mice and DN3 thymocytes from SCID, and RAG1
-/- mice were stained as in (A). A higher 
magnification view of the insets (marked with white boxes) in the ‘merge’ panels is shown on the right side. Experiment 
representative of at least three independent experiments. (C) Graph displaying the percentage of cells demonstrating p38 
MAPK nuclear accumulation in different cell populations (total count >150 cells per population, counted from 3 independent 
areas of visualization). Error bars represent SEM. Data representative of four experiments and multiple fields of view. 
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Discussion 
p38 MAPK has no nuclear localization signal, 
and it is believed to be diffused throughout the nu-
cleus and the cytoplasm. In this study, we show that 
p38 MAPK accumulates in the nucleus specifically in 
response to stimuli that induce DSBs, but not by other 
stimuli (e.g. TNFα, FasL) that also activate p38 
MAPK. The intracellular distribution of p38 MAPK 
can therefore be determined by the nature of the 
stimuli and can influence p38 MAPK targets. Thus, 
DNA damage stimuli promotes nuclear accumulation 
of p38 MAPK for this kinase to phosphorylate poten-
tial nuclear targets (e.g. p53) involved in the induc-
tion of cell cycle checkpoints. However, arsenite 
treatment has been shown to promote cytoplasmic 
accumulation of p38 MAPK [17]. 
We also show here that nuclear translocation of 
p38 MAPK in response to DNA damage stimuli re-
quires phosphorylation of Thr180/Tyr182 by MKK3 
and/or MKK6, but it does not require its catalytic 
activity. This suggests that phosphorylation of these 
residues may induce a conformational change that 
unmasks a domain enabling p38 MAPK to interact 
with a nuclear shuttling chaperone to mediate its 
re-localization to the nucleus. To date, we cannot 
conclude whether phosphorylation of one or both 
residues is necessary for nuclear translocation. The 
results showing that BIRB 796, but not SB203580, re-
stores nuclear localization of dnp38 MAPK further 
support the effect of a conformational change. Since 
phosphorylation of p38 MAPK in response to DNA 
damage, but not in response to other stimuli, pro-
motes nuclear accumulation, it is possible that this 
nuclear shuttle is also specifically induced or acti-
vated by DNA damage, as described for NBS1 [31] 
and GADD45 [32, 33]. Thus, selective nuclear trans-
port of p38 MAPK would require both its phos-
phorylation as well as the active nuclear shuttle to be 
present. Alternatively, DNA damage signals could 
also release p38 MAPK from docking molecules that 
retain p38 MAPK in the cytosol. In this regard, p38 
MAPK strongly associates with MAPKAP kinase-2 
(MAPKAPK2), a substrate for p38 MAPK which con-
tains both nuclear localization and nuclear export 
sequences [34]. Binding of phosphorylated 
MAPKAPK2 to p38 MAPK appears to promote the 
retention of p38 MAPK in the cytosol [17]. Similarly, 
binding of TAB-1 (TAK-1 binding protein) to p38 
MAPK also directs localization to the cytosol, and 
induces p38 MAPK autophosphorylation in a 
MAPKK-independent manner [35, 36]. It is plausible 
that the conformational change of p38 MAPK upon 
DNA damage disrupt its interaction with 
MAPKAPK2 or TAB1, enabling its accumulation in 
the nucleus. 
Several studies have shown a role for p38 
MAPK in the induction of a G2/M cell cycle check-
point in response to DNA damage (ionizing radia-
tion, UV), and phosphorylation of targets involved in 
this checkpoint such as p53 or Cdc25 [12, 37-39]. p38 
MAPK is also activated by V(D)J-mediated DSBs and 
induces a G2/M cell cycle checkpoint in DN3 thy-
mocytes [30], suggesting that V(D)J-mediated DSBs 
also represent DNA damage signals. We show here 
nuclear accumulation of p38 MAPK specifically in 
DN3 thymocytes undergoing V(D)J recombination 
(wild type and SCID), but not in DN3 thymocytes 
from RAG deficient mice. Thus, similar to the DSBs 
induced by ionizing radiation, V(D)J-mediated DSBs 
appear to be interpreted as a DNA damage signal. 
Recent studies have shown that signal ended DNA 
fragments released during V(D)J recombination of the 
TCRβ gene can integrate into different chromosomal 
locations, by either insertion or transposition [40-45], 
and may lead to genomic instability and potential 
malignancies. The selective nuclear accumulation of 
p38 MAPK in response to DNA damage could pose a 
mechanism to facilitate the phosphorylation of p38 
MAPK nuclear targets for the induction of a G2/M 
cell cycle checkpoint and DNA repair. 
In summary, the intracellular localization of p38 
MAPK is regulated upon activation of this kinase, 
and is dependent on the stimuli involved. This most 
likely reflects the requirement of p38 MAPK to be in 
close proximity to its targets. 
Materials and Methods 
Mice. 
Wild type, RAG1-/-, and SCID mice were pur-
chased from Jackson Laboratories. MKK3-/-and 
MKK6-/- single mice have been previously reported 
[46]. MKK3-/-/MKK6+/- were obtained by serial in-
tercrosses of MKK3-/- and MKK6-/- single mice as 
previously reported [8]. Mice (five to seven weeks of 
age) were bred and maintained in specific patho-
gen-free conditions. Procedures involving mice were 
approved by institutional guidelines for animal care. 
Cell Preparation, Transfection, and Stimulation. 
HEK293T cells were transfected using calcium 
phosphate. Following exposure to UV (1.5 mins, 15 
J/m2), or X-radiation (2.8 Gy) (RadSource 2000, GA) 
cells were rested at 37°C for 30 mins. SB203580 (Cal-
biochem, CA) and BIRB 796 (Axon Medchem) pre-
treatment (5 μM) was performed at 37°C for 40 mins, 
prior to cell stimulation. Cells were additionally 
stimulated with PMA (Sigma) (10 ng/ml), TNFα Int. J. Biol. Sci. 2009, 5 
 
http://www.biolsci.org 
436
(R&D Systems, MN) (10 ng/ml), or Ig-FasL (Alexis 
Biochemicals, CA) (200 ng/ml) and anti-Flag M2 
mouse monoclonal antibody (Sigma) (4 μg/ml) at 
37°C for 30 mins, prior to fixation. DN3 and DN4 
thymocytes were purified and stained (CD4, CD8, 
CD25, and CD44 BD Biosciences), sorted (FacsAria, 
BD Biosciences), and collected.   
Confocal Microscopy and Analysis. 
Staining of 293T [47] cells and thymocytes [30] 
was performed as we previously published. Briefly, 
cells were fixed, permeabilized and stained with pri-
mary antibody followed by fluorescently labeled 
secondary antibody. The primary antibodies used 
included the rabbit anti-p38 MAPK polyclonal anti-
body (Santa Cruz, CA), mouse anti-γH2AX mono-
clonal antibody (Upstate, Millipore), rabbit 
anti-phospho-p38 MAPK monoclonal antibody #9215 
recognizing p38 MAPK dually phosphorylated on 
Thr180/Tyr182 (Cell Signaling, MA). Secondary anti-
bodies used include Alexa Fluor 
anti-mouse/anti-rabbit 488/567 highly adsorbed an-
tibodies (Invitrogen). Topro-3 and YoYo were used as 
nuclear stains. Images of fixed cells were acquired on 
a Zeiss LSM-510 upright microscope using a 63x Plan 
Apochromat Ph3 objective lens. 
Western Blot. 
Whole cell extracts were prepared in Triton lysis 
buffer (TLB) and used for Western blot analysis as we 
previously described [30] using anti-p38 MAPK 
(Santa Cruz, CA) and anti-phospho-p38 MAPK (Cell 
Signaling, MA). Anti-rabbit HRP, and anti-mouse 
HRP (Santa Cruz, CA) were used as secondary anti-
bodies. 
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